Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer that has come back (recurred) in the same area, confirmed by a tissue sample (biopsy), where surgery either left very little margin (1mm or less), did not fully remove the cancer, or where the recurrence cannot be surgically removed at all
- People aged 18 or older
- People who are reasonably well and able to carry out daily activities (this is measured using a standard scale called ECOG, scores 0–2 — confirm with trial site what this means for a specific situation)
- People whose life expectancy is estimated to be more than 2 years
- People who have given their written informed consent to participate
Who may not be able to join:
- People with widespread cancer that has spread to distant parts of the body, where life expectancy is estimated to be less than 2 years
- People with serious heart conditions, including severe heart failure, coronary heart disease, a heart attack within the last 6 months, or a significant type of abnormal heart rhythm called AV block III° (confirm with trial site)
- People who have a cardiac pacemaker
- People who have or have had another type of cancer, unless it is certain types that are considered low-risk or have been successfully treated more than 5 years ago (such as early-stage cervical, skin, or bladder cancers — confirm with trial site for specific cases)
- People who are pregnant or breastfeeding
- People who have an implanted port (a small medical device used to deliver medication) on the same side of the body that would be treated
- People who have had a blood clot in the subclavian vein (a large vein near the shoulder) within the last 6 months
- People whose circumstances make it not possible to safely receive the hyperthermia (heat-based) treatment used in this trial (confirm with trial site)
- People who would not be able to attend regular follow-up appointments as required by the trial
- People who have had an organ transplant
- People who have other implanted devices or materials in the chest wall on the same side as the area to be treated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vanessa Heinrich, MD, University Hospital Tübingen
Phone: +49 (0) 7071 29-
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the health-related Quality of Life (QoL) during and after hyperthermic radiotherapy. QoL will be measured by the EORTC QLQ BR 23
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.